Development of personalized treatment strategies by analyzing patient data and prediction of treatment outcomes for enhanced patient selection and monitoring processes as well as tracking the side effects of GLP-1 receptor agonist (GLP-1 RA) therapies can be streamlined with the integration of AI
BPC-157 is generally thought to be safe, but some side effects that may occur include dizziness, headaches, and changes in appetite
This strategy supports sustained benefits over extended use rather than short-lived gains
Specific barriers that participants face may include (1) mistrust, (2) lack of comfort with the clinical trial process, (3) lack of information about clinical trials, (4) time and resource constraints associated with participation, and (5) lack of awareness about the existence and importance of clinical trials (Clark et al., 2019)
"2021 International Sports Hall of Fame Inductees"
Supplementary material The Supplementary Material for this article can be found online at: Abbreviations CS, chondroitin sulfate